We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Consumer Discretionary 9.92%
3 Healthcare 7.34%
4 Financials 7.06%
5 Communication Services 6.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPO
3651
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
$758K ﹤0.01%
+45,452
New +$846K
ED icon
3652
Consolidated Edison
ED
$40B
$757K ﹤0.01%
10,430
-326,064
-97% -$24.3M
NICE icon
3653
Nice
NICE
$5.92B
$757K ﹤0.01%
2,666
-17,696
-87% -$4.91M
SMP icon
3654
Standard Motor Products
SMP
$829M
$757K ﹤0.01%
17,311
-39,708
-70% -$1.7M
ARVL
3655
DELISTED
Arrival Ordinary Shares
ARVL
$757K ﹤0.01%
1,151
-3,857
-77% -$2.47M
JNPR
3656
DELISTED
Juniper Networks
JNPR
$756K ﹤0.01%
27,459
-364,280
-93% -$10.3M
BLMN icon
3657
CALL
Bloomin' Brands
BLMN
$955M
$755K ﹤0.01%
30,200
SHW icon
3658
PUT
Sherwin-Williams
SHW
$84.6B
$755K ﹤0.01%
2,700
CNM icon
3659
Core & Main
CNM
$8.12B
$754K ﹤0.01%
+28,778
New +$766K
APO icon
3660
Apollo Global Management
APO
$78.9B
$752K ﹤0.01%
12,210
+1,847
+18% +$111K
IOVA icon
3661
PUT
Iovance Biotherapeutics
IOVA
$3.66B
$752K ﹤0.01%
30,500
FTCH
3662
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$750K ﹤0.01%
20,000
-100,000
-83% -$4.43M
GEOS icon
3663
Geospace Technologies
GEOS
$67.1M
$749K ﹤0.01%
78,464
-8,860
-10% -$81.7K
PETQ
3664
PUT
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$749K ﹤0.01%
+30,000
New +$904K
ONEM
3665
DELISTED
1Life Healthcare
ONEM
$747K ﹤0.01%
36,902
-41,837
-53% -$1.08M
SRSA
3666
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$747K ﹤0.01%
75,776
+38,080
+101% +$374K
SAIC icon
3667
Saic
SAIC
$5.39B
$745K ﹤0.01%
8,704
+3,198
+58% +$274K
FTAA
3668
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
$745K ﹤0.01%
+75,444
New +$745K
VOSO
3669
DELISTED
Virtuoso Acquisition Corp. Class A Common Stock
VOSO
$745K ﹤0.01%
75,171
MAC icon
3670
CALL
Macerich
MAC
$6.86B
$744K ﹤0.01%
44,500
BNR
3671
Burning Rock Biotech
BNR
$110M
$743K ﹤0.01%
+4,156
New +$924K
RRX icon
3672
Regal Rexnord
RRX
$11B
$743K ﹤0.01%
4,940
-692
-12% -$99.3K
GDEN
3673
DELISTED
Golden Entertainment
GDEN
$742K ﹤0.01%
15,118
+1,430
+10% +$66.5K
DFNS
3674
T3 Defense Inc
DFNS
$12M
$742K ﹤0.01%
102
RS icon
3675
PUT
Reliance Steel & Aluminium
RS
$20B
$741K ﹤0.01%
5,200

Similar funds

David Shaw's Q3 2021 Portfolio in Review

As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, David Shaw opened a new position in Sea Limited worth $206M.

  • David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • David Shaw opened 915 new positions and closed 695 in Q3 2021.
  • David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.